Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives in Community-Based and Hospital-Based Approaches
January 26, 2024 updated by: Porntip Nitikarun, Phrapokklao Hospital,Thailand
In conclusion, the study shows that the hospital-based group had a significantly higher screening uptake than the community-based group, reflecting that information from ophthalmologists and registered ophthalmic nurses is more effective and well-received than that from village health volunteers.
The study suggests that increasing education and support for village health volunteers could enhance screening uptake.
Factors influencing uptake include the age of FDRs, place of residence, education, presenting VA of probands, and treatment of probands.
Utilizing this study's findings, spreading knowledge and training health officials at the district and sub-district levels could increase understanding of glaucoma and improve communication with the general public and at-risk groups, potentially increasing the response rate.
Additionally, implementing a national free screening glaucoma program for at-risk populations, both in and outside hospitals, and organizing mobile screening units at the district level could be an effective prevention strategy against permanent vision loss from glaucoma.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
1304
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chanthaburi, Thailand, 22000
- Phrapokklao Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
These probands were then divided into two non-randomized groups: The first group, hospital-based, included all probands receiving treatment in the ophthalmology outpatient department from 1 dec 2022 to 28 feb 2023. These patients received information about glaucoma from ophthalmologists and registered ophthalmic nurses, along with a brochure.
These patients were asked to invite FDRs-parents, siblings, and offspring aged 40 years and above - to participate screening.
The second group, community-based, involved randomly selecting districts in Chanthaburi In this group, village health volunteers trained in glaucoma knowledge by ophthalmologists distributed brochures and educated patients and FDRs, similar to the hospital-based group. These FDRs were then invited to participate in the glaucoma screening program one month later, with ophthalmologists at health stations near homes in Muang district and Laem Sing Hospital between 1 mar 2023 to 31 may 2023.
Description
Inclusion Criteria:
- All patients with POAG who had a treatment history in the ophthalmology outpatient department of Prapokklao Hospital, Chanthaburi Province, were identified from the Electronic Medical Record (EMR) database with the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) " Primary open angle glaucoma H40.1" between 1 january 2022 to 31 october 2022. A total of 1304 patients were included in this study.
Exclusion Criteria:
- Excluding those with closed-angle glaucoma and secondary glaucoma due to other conditions such as accidents, post-surgical complications, uveitis, or congenital.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
This study aimed to evaluate the differences in glaucoma screening uptake among FDRs in community and hospital-based settings
Time Frame: Jan 1,2022-May 31,2023
|
All patients with POAG who had a treatment history in OPD of Prapokklao Hospital, Chanthaburi Province, were identified from EMR database with ICD-10 "H40.1".
These probands were then divided into two non-randomized groups: The first group, hospital-based, these patients received information from ophthalmologists and registered ophthalmic nurses, along with a brochure .Subsequently, these patients were asked to invite their FDRs - aged 40 years and above - to participate in screening.
The second group, community-based, involved randomly selecting districts in Chanthaburi Province for screening, including Muang and Laem Sing districts.
After excluded the patients already participating in the hospital-based group from the EMR database, 682 probands remained in the second group.
In this group, village health volunteers trained in glaucoma knowledge by ophthalmologists distributed brochures and educated patients and FDRs.
|
Jan 1,2022-May 31,2023
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
This study investigated the determinants influencing participation in glaucoma screening programs and the prevalence of glaucoma in FDRs.
Time Frame: Jan 1,2022-May 31,2023
|
All glaucoma patients and their FDRs underwent a detailed by history taking information such as age, underlying disease, address, time of diagnosis glaucoma, medical history treatment of glaucoma and relationship with the glaucoma patient.
|
Jan 1,2022-May 31,2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2022
Primary Completion (Actual)
December 1, 2022
Study Completion (Actual)
May 31, 2023
Study Registration Dates
First Submitted
January 18, 2024
First Submitted That Met QC Criteria
January 18, 2024
First Posted (Actual)
January 26, 2024
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 26, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Phrapokklao Hospital
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.